OpenAI CEO Sam Altman publicly rejected a staggering $97.4 billion offer from Elon Musk and other investors for control of the AI company. The offer, reported by the Wall Street Journal, sparked a heated exchange on social media, highlighting the ongoing feud between Altman and Musk. Altman's response included a cheeky proposal to buy Twitter for $9.74 billion instead, showcasing the tension between their competing visions for AI development.
The rejected bid aims to establish a valuation floor for OpenAI's assets, particularly its flagship product, ChatGPT. Musk's interest in merging OpenAI with his x.AI venture reflects a desire to return to the open-source principles that initially guided OpenAI's creation. This situation underscores the complexities of transitioning from a nonprofit to a for-profit model in the rapidly evolving AI landscape.
• Altman rejects Musk's $97.4 billion offer for OpenAI control.
• Musk proposes merging OpenAI with his x.AI venture.
OpenAI is an AI research organization focused on developing and promoting friendly AI technologies.
ChatGPT is a conversational AI model developed by OpenAI, known for its advanced natural language processing capabilities.
AI is a venture initiated by Elon Musk aimed at developing AI technologies with an open-source ethos.
OpenAI is central to the article as it navigates a potential shift from nonprofit to for-profit status.
Tesla, owned by Musk, is mentioned in the context of Musk's influence and wealth in the AI sector.
Fox Business on MSN.com 2month
Microsoft is reportedly eyeing more of its own AI models into Copilot and reduce dependency on OpenAI. It's also exploring rivals such as DeepSeek and Meta.
The US Department of Justice is still calling for Google to sell its web browser Chrome, according to a Friday court filing. The DOJ first proposed
At SXSW, Signal President Meredith Whittaker warned about the 'profound' security risks to user privacy posed by agentic AI.
Producing high-performance titanium alloy parts -- whether for spacecraft, submarines or medical devices -- has long been a slow, resource-intensive process. Even with advanced metal 3D-printing techniques,